Gyre Therapeutics, Inc. (GYRE)
6.70
+0.01
(+0.15%)
USD |
NASDAQ |
Sep 16, 16:00
6.70
0.00 (0.00%)
After-Hours: 17:21
Gyre Therapeutics Total Assets (Quarterly) : 199.26M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 199.26M |
| March 31, 2026 | 162.02M |
| December 31, 2025 | 166.13M |
| September 30, 2025 | 159.38M |
| June 30, 2025 | 152.65M |
| March 31, 2025 | 129.79M |
| December 31, 2024 | 125.41M |
| September 30, 2024 | 125.24M |
| June 30, 2024 | 120.93M |
| March 31, 2024 | 122.01M |
| December 31, 2023 | 116.54M |
| September 30, 2023 | 9.964M |
| June 30, 2023 | 12.39M |
| March 31, 2023 | 18.75M |
| December 31, 2022 | 84.75M |
| September 30, 2022 | 31.02M |
| June 30, 2022 | 83.37M |
| March 31, 2022 | 40.27M |
| December 31, 2021 | 55.66M |
| September 30, 2021 | 78.54M |
| June 30, 2021 | 101.79M |
| March 31, 2021 | 119.08M |
| December 31, 2020 | 94.85M |
| September 30, 2020 | 111.80M |
| June 30, 2020 | 123.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 110.56M |
| December 31, 2019 | 98.55M |
| September 30, 2019 | 91.79M |
| June 30, 2019 | 100.87M |
| March 31, 2019 | 111.87M |
| December 31, 2018 | 124.92M |
| September 30, 2018 | 133.42M |
| June 30, 2018 | 139.54M |
| March 31, 2018 | 145.89M |
| December 31, 2017 | 39.51M |
| September 30, 2017 | 34.39M |
| June 30, 2017 | 39.63M |
| March 31, 2017 | 29.06M |
| December 31, 2016 | 38.09M |
| September 30, 2016 | 51.62M |
| June 30, 2016 | 57.22M |
| March 31, 2016 | 61.54M |
| December 31, 2015 | 69.52M |
| September 30, 2015 | 74.51M |
| June 30, 2015 | 101.17M |
| March 31, 2015 | 107.14M |
| December 31, 2014 | 2.981M |
| September 30, 2014 | 116.12M |
| June 30, 2014 | 124.52M |
| March 31, 2014 | 134.11M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cytokinetics, Inc. | 1.925B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.51M |
| Shareholders Equity (Quarterly) | 130.36M |
| Debt to Equity Ratio | 0.0262 |
| Current Ratio | 4.259 |
| Net Debt Paydown Yield | -0.05% |